Get the Stockscreener App
1.51
5.63%
-0.09
After Hours:
29.72
28.21
+1,868%
Relmada Therapeutics Inc stock is traded at $1.51, with a volume of 264.56K.
It is down -5.63% in the last 24 hours and up +133.71% over the past month.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
See More
Previous Close:
$1.60
Open:
$1.63
24h Volume:
264.56K
Relative Volume:
0.39
Market Cap:
$50.12M
Revenue:
-
Net Income/Loss:
$-98.79M
P/E Ratio:
-0.4618
EPS:
-3.27
Net Cash Flow:
$-51.66M
1W Performance:
-6.21%
1M Performance:
+133.71%
6M Performance:
+412.39%
1Y Performance:
-56.10%
1-Day Range:
$1.50
$1.6494
1-Week Range:
$1.44
$1.9346
52-Week Range:
$0.2404
$3.98
Relmada Therapeutics Inc Stock (RLMD) Company Profile
Name
Relmada Therapeutics Inc
Sector
Industry
Phone
646 876 3459
Address
2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, NY
Compare RLMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 3.03 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
3.04 | 3.95B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.38 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.2195 | 93.94M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.3082 | 689.83M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.1801 | 0 | 0 | 0 | 0 | 0.00 |
Relmada Therapeutics Inc Stock (RLMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-05-24 | Downgrade | Mizuho | Outperform → Neutral |
| Sep-17-24 | Upgrade | Jefferies | Hold → Buy |
| Jun-05-24 | Downgrade | Goldman | Neutral → Sell |
| Oct-14-22 | Downgrade | Goldman | Buy → Neutral |
| Oct-14-22 | Downgrade | Guggenheim | Buy → Neutral |
| Oct-14-22 | Downgrade | Truist | Buy → Hold |
| Oct-13-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-18-21 | Initiated | Mizuho | Buy |
| May-20-21 | Resumed | Goldman | Buy |
| Oct-28-20 | Downgrade | Goldman | Buy → Neutral |
| Jul-14-20 | Initiated | Oppenheimer | Outperform |
| May-04-20 | Initiated | SunTrust | Buy |
| Apr-21-20 | Initiated | Goldman | Buy |
| Jan-27-20 | Initiated | Jefferies | Buy |
| Jan-10-20 | Initiated | SVB Leerink | Outperform |
| Dec-16-19 | Initiated | Guggenheim | Buy |
View All
Relmada Therapeutics Inc Stock (RLMD) Latest News
Measuring Relmada Therapeutics Inc.’s beta against major indices2025 Key Lessons & Free Accurate Trade Setup Notifications - newser.com
Relmada Therapeutics Updates Corporate Presentation on NDV-01 - TipRanks
Short interest data insights for Relmada Therapeutics Inc.Forecast Cut & Weekly Setup with ROI Potential - newser.com
Is Relmada Therapeutics Inc in a long term uptrendJuly 2025 WrapUp & Risk Controlled Swing Trade Alerts - خودرو بانک
Using Python tools to backtest Relmada Therapeutics Inc. strategiesWeekly Trade Recap & Reliable Breakout Stock Forecasts - newser.com
IPO Launch: Is Relmada Therapeutics Inc a speculative investmentStop Loss & AI Optimized Trading Strategy Guides - خودرو بانک
Regression analysis insights on Relmada Therapeutics Inc. performanceWeekly Earnings Recap & Stepwise Swing Trade Plans - newser.com
Aug Sectors: Is Relmada Therapeutics Inc a speculative investmentEarnings Risk Report & Consistent Income Trade Ideas - خودرو بانک
Relmada Therapeutics Inc. stock trendline breakdownQuarterly Growth Report & Technical Buy Zone Confirmations - newser.com
Setup Watch: Whats the RSI of Relmada Therapeutics Inc stockWeekly Trend Recap & Weekly Momentum Stock Picks - خودرو بانک
Market Review: How does Relmada Therapeutics Inc compare to its peersLong Setup & Precise Swing Trade Alerts - خودرو بانک
Relmada Regains Compliance with Nasdaq Minimum Bid Price Requirement - Investing News Network
Patterns Watch: Is Relmada Therapeutics Inc a speculative investmentWeekly Volume Report & Real-Time Buy Zone Alerts - خودرو بانک
Relmada regains Nasdaq compliance on minimum bid price - MSN
Relmada Therapeuticsregains compliance with Nasdaq minimum bid priceSEC filing - MarketScreener
Relmada Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement - Quiver Quantitative
Clinical-Stage Biotech Relmada Therapeutics Secures Future on Nasdaq After Meeting Listing Requirements - Stock Titan
Aug PreEarnings: How does Relmada Therapeutics Inc compare to its peersQuarterly Market Review & Community Trade Idea Sharing - خودرو بانک
Using flow based indicators on Relmada Therapeutics Inc.2025 Market Overview & Trade Opportunity Analysis - newser.com
How hedge fund analytics apply to Relmada Therapeutics Inc. stockJuly 2025 Gainers & Stepwise Trade Signal Implementation - newser.com
Patterns Watch: Is Relmada Therapeutics Inc in a long term uptrendQuarterly Market Review & AI Enhanced Trading Signals - خودرو بانک
Published on: 2025-09-15 17:44:42 - newser.com
Intraday pattern recognizer results for Relmada Therapeutics Inc.2025 Breakouts & Breakdowns & Community Shared Stock Ideas - newser.com
What MACD and RSI say about Relmada Therapeutics Inc.July 2025 Analyst Calls & Daily Stock Trend Watchlist - newser.com
Using data tools to time your Relmada Therapeutics Inc. exit2025 Risk Factors & Safe Swing Trade Setup Alerts - newser.com
Aug Update: What is Relmada Therapeutics Inc. s revenue forecastMarket Performance Report & Real-Time Chart Pattern Alerts - خودرو بانک
Weekly Earnings: How do insiders feel about Relmada Therapeutics IncTrade Exit Summary & Entry Point Confirmation Signals - خودرو بانک
Using data models to predict Relmada Therapeutics Inc. stock movementWeekly Stock Analysis & Short-Term High Return Ideas - newser.com
Published on: 2025-09-14 23:04:00 - newser.com
Published on: 2025-09-14 14:05:14 - newser.com
Using data filters to optimize entry into Relmada Therapeutics Inc.Analyst Downgrade & Consistent Profit Trade Alerts - newser.com
Top chart patterns to watch in Relmada Therapeutics Inc.Trade Volume Report & Weekly Market Pulse Updates - Newser
Is now a turning point for Relmada Therapeutics Inc.July 2025 Gainers & Verified Technical Signals - Newser
Real time social sentiment graph for Relmada Therapeutics Inc.Trade Analysis Summary & Reliable Price Breakout Alerts - Newser
Applying chart zones and confluence areas to Relmada Therapeutics Inc.2025 Investor Takeaways & Verified Momentum Stock Alerts - Newser
Real time pattern detection on Relmada Therapeutics Inc. stockJuly 2025 Reactions & Long-Term Growth Plans - Newser
Building trade automation scripts for Relmada Therapeutics Inc.Treasury Yields & AI Powered Market Entry Strategies - Newser
Will Relmada Therapeutics Inc. rebound enough to break evenPortfolio Return Report & Weekly Market Pulse Updates - Newser
Relmada Therapeutics Inc Stock (RLMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.62%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):